AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24282565 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Teams (MTs) providing counseling, condoms, screening and treatment for Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT), and Trichomonas vaginalis (TV) infections; presumptive metronidazole treatment.
Number of subjects: 24814
Study 24282565 — intervention group
Group type: COMPARATOR
Intervention: Control cities (matched control group)
Number of subjects: 24814
Study 21539680 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 µg daily
Number of subjects: 362
Study 21539680 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 362
Study 21539680 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 362
Study 18997675 — intervention group
Group type: EXPERIMENTAL
Intervention: BUP (300 mg) + NAL (50 mg)
Number of subjects: 0
Study 22240178 — intervention group
Group type: EXPERIMENTAL
Intervention: E₂V/DNG
Number of subjects: 355
Study 22240178 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 355
Study 15943843 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine
Number of subjects: 21
Study 15943843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 12637255 — intervention group
Group type: EXPERIMENTAL
Intervention: Nandrolone (600 mg/wk) + Resistance Training (RT)
Number of subjects: 2
Study 12637255 — intervention group
Group type: COMPARATOR
Intervention: Nandrolone (600 mg/wk)
Number of subjects: 2
Study 12637255 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxandrolone (20 mg/day)
Number of subjects: 2
Study 12637255 — intervention group
Group type: COMPARATOR
Intervention: Oxandrolone (20 mg/day) + Placebo
Number of subjects: 2
Study 10539752 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 microgram Se as L-selenomethionine
Number of subjects: 52
Study 10539752 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 microgram Se as L-selenomethionine
Number of subjects: 52
Study 10539752 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 microgram Se as L-selenomethionine
Number of subjects: 52
Study 10539752 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 microgram Se as L-selenomethionine
Number of subjects: 52
Study 10539752 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 7484820 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 166
Study 7484820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 166
Study 2186982 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate
Number of subjects: 73
Study 2186982 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 6893252 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite meals with chicken protein
Number of subjects: 0
Study 6893252 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite meals with beef protein
Number of subjects: 0
Study 6893252 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite meals with soybean protein
Number of subjects: 0
Study 6893252 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite meals with increased calcium content (milk added to soybean meal)
Number of subjects: 0
Study 6893252 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite meals with total zinc content
Number of subjects: 0
Study 31568796 — intervention group
Group type: EXPERIMENTAL
Intervention: One 6-nmol intradermal injection every 2 weeks for 14 weeks
Number of subjects: 207
Study 31568796 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study 29664339 — intervention group
Group type: EXPERIMENTAL
Intervention: MR imaging (n = 179) within 2 weeks after injury
Number of subjects: 356
Study 29664339 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n = 177; MR imaging not performed)
Number of subjects: 356
Study 29664339 — intervention group
Group type: EXPERIMENTAL
Intervention: MR imaging (n = 179)
Number of subjects: 356
Study 29664339 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n = 177)
Number of subjects: 356
Study 28245835 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitation of creams availability and continuous electronic monitoring of consumption with regular feedback on skin care performance.
Number of subjects: 504
Study 28245835 — intervention group
Group type: COMPARATOR
Intervention: Basic education on skin protection (as 'care as usual').
Number of subjects: 504
Study 25840779 — intervention group
Group type: EXPERIMENTAL
Intervention: Printed Decision Support (PDS)
Number of subjects: 0
Study 25840779 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer Decision Support (CDS)
Number of subjects: 0
Study 25840779 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 0
Study 23954997 — intervention group
Group type: EXPERIMENTAL
Intervention: Immune tolerance group
Number of subjects: 40
Study 23954997 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactive hepatitis B surface antigen carriers group
Number of subjects: 40
Study 23954997 — intervention group
Group type: EXPERIMENTAL
Intervention: Resolved hepatitis B group
Number of subjects: 40
Study 23954997 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 20457158 — intervention group
Group type: EXPERIMENTAL
Intervention: Omentectomy plus Roux-en-Y gastric bypass (RYGB)
Number of subjects: 29
Study 20457158 — intervention group
Group type: EXPERIMENTAL
Intervention: Omentectomy alone
Number of subjects: 29
Study 17940809 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin (2,850/3,800 U daily subcutaneous)
Number of subjects: 20
Study 17940809 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 20
Study 17940809 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin
Number of subjects: 20
Study 17940809 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study 16645445 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypercapnia (end‐tidal carbon dioxide tension 50 mmHg)
Number of subjects: 30
Study 16645445 — intervention group
Group type: COMPARATOR
Intervention: Normocapnia (end‐tidal carbon dioxide tension 35 mmHg)
Number of subjects: 30
Study 12957685 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) levels
Number of subjects: 440
Study 12957685 — intervention group
Group type: EXPERIMENTAL
Intervention: Low HOMA-S
Number of subjects: 440
Study 12957685 — intervention group
Group type: EXPERIMENTAL
Intervention: Low IGFBP-1
Number of subjects: 440
Study 12957685 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP increase
Number of subjects: 440
Study 12957685 — intervention group
Group type: EXPERIMENTAL
Intervention: High CRP, low IGF-I, low IGFBP-1
Number of subjects: 440
Study 12957685 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin sensitivity in obese subjects
Number of subjects: 440
Study 12957685 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin sensitivity in non-obese subjects
Number of subjects: 440
Study 11037041 — intervention group
Group type: EXPERIMENTAL
Intervention: Distinctive words with varying character sizes
Number of subjects: 0
Study 11037041 — intervention group
Group type: EXPERIMENTAL
Intervention: Distinctive words surrounded by a frame (close or far distance)
Number of subjects: 0
Study 8645511 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential treatment with prednisone for 6 weeks followed by alpha‐2a interferon (IFN) for 6 months (group A)
Number of subjects: 18
Study 8645511 — intervention group
Group type: COMPARATOR
Intervention: Concomitant administration of prednisone and IFN (group B)
Number of subjects: 18
Study 8645511 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (anti-HBe patients)
Number of subjects: 18
Study 8645511 — intervention group
Group type: COMPARATOR
Intervention: Group B (anti-HBe patients)
Number of subjects: 18
Study 8645511 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment response
Number of subjects: 18
Study 1536049 — intervention group
Group type: COMPARATOR
Intervention: Verapamil therapy (120 mg thrice daily)
Number of subjects: 1595
Study 1536049 — intervention group
Group type: COMPARATOR
Intervention: Verapamil therapy (360 mg daily)
Number of subjects: 1595
Study 6678823 — intervention group
Group type: EXPERIMENTAL
Intervention: Domifen bromide in combination with antibiotics
Number of subjects: 29
Study 6678823 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 29103528 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive n-back working memory training
Number of subjects: 0
Study 29103528 — intervention group
Group type: COMPARATOR
Intervention: Active control task
Number of subjects: 0
Study 27488183 — intervention group
Group type: EXPERIMENTAL
Intervention: Yam bean root juice (500 ml)
Number of subjects: 30
Study 27488183 — intervention group
Group type: EXPERIMENTAL
Intervention: Guava fruit juice (500 ml)
Number of subjects: 30
Study 27488183 — intervention group
Group type: COMPARATOR
Intervention: Water (500 ml)
Number of subjects: 30
Study 24706693 — intervention group
Group type: EXPERIMENTAL
Intervention: Video instruction
Number of subjects: 30
Study 24706693 — intervention group
Group type: EXPERIMENTAL
Intervention: Faculty-led hands-on instruction
Number of subjects: 30
Study 24706693 — intervention group
Group type: EXPERIMENTAL
Intervention: Both video and hands-on instruction
Number of subjects: 30
Study 22350254 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 99
Study 22350254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 19752016 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct bonding method (Group 1)
Number of subjects: 40
Study 19752016 — intervention group
Group type: COMPARATOR
Intervention: Indirect bonding method with Transbond XT and Sondhi Rapid Set A/B Primer (Group 2)
Number of subjects: 40
Study 18297259 — intervention group
Group type: EXPERIMENTAL
Intervention: Brisk walking (3 times a week for 60 min)
Number of subjects: 92
Study 18297259 — intervention group
Group type: COMPARATOR
Intervention: Medical fitness programme
Number of subjects: 92
Study 18297259 — intervention group
Group type: EXPERIMENTAL
Intervention: Brisk walking
Number of subjects: 92
Study 15994614 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypropylene mesh
Number of subjects: 100
Study 15994614 — intervention group
Group type: COMPARATOR
Intervention: Fascia lata
Number of subjects: 100
Study 12909502 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous unfractionated heparin (5000 IU b.i.d.) and aspirin (100 mg daily)
Number of subjects: 143
Study 12909502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study 11865427 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 doses of subunit CMV glycoprotein B (gB) vaccine plus MF59
Number of subjects: 105
Study 11865427 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 doses of canarypox recombinant vaccine expressing CMVgB (ALVAC-CMVgB) followed by 2 doses of the subunit gB vaccine
Number of subjects: 105
Study 11865427 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 doses of both vaccines administered concomitantly
Number of subjects: 105
Study 11865427 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 11501128 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 42
Study 11501128 — intervention group
Group type: COMPARATOR
Intervention: Non-HBOT
Number of subjects: 42
Study 7494621 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-linolenic acid-enriched diet
Number of subjects: 0
Study 7494621 — intervention group
Group type: COMPARATOR
Intervention: Prudent diet of the American Heart Association (control)
Number of subjects: 0
Study 7494621 — intervention group
Group type: COMPARATOR
Intervention: Control group overall mortality
Number of subjects: 0
Study 7494621 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group overall mortality
Number of subjects: 0
Study 2228923 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.3 mg/kg
Number of subjects: 11
Study 2228923 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.6 mg/kg
Number of subjects: 11
Study 2228923 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 2228923 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (both doses)
Number of subjects: 11
Study 2228923 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 11
Study 2228923 — intervention group
Group type: COMPARATOR
Intervention: Parent instruments
Number of subjects: 11
Study 6996341 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfametrol-trimethoprim (Lidaprim)
Number of subjects: 20
Study 31806413 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) for 3 months
Number of subjects: 301
Study 31806413 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 301
Study 30704982 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose solution
Number of subjects: 30
Study 30704982 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 30
Study 27180818 — intervention group
Group type: EXPERIMENTAL
Intervention: DVD-delivered exercise intervention
Number of subjects: 153
Study 27180818 — intervention group
Group type: COMPARATOR
Intervention: Attentional control condition
Number of subjects: 153
Study 25887302 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational medicine intervention
Number of subjects: 300
Study 25887302 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 300
Study 24171490 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 2218
Study 24171490 — intervention group
Group type: COMPARATOR
Intervention: Control (unfractionated or low-molecular-weight heparin with optional glycoprotein IIb/IIIa inhibitors)
Number of subjects: 2218
Study 20399573 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 14
Study 20399573 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 19255200 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-incision total hip arthroplasty
Number of subjects: 72
Study 19255200 — intervention group
Group type: COMPARATOR
Intervention: Mini-posterior-incision total hip arthroplasty
Number of subjects: 72
Study 17355268 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 1823
Study 17355268 — intervention group
Group type: COMPARATOR
Intervention: Placebo or Nontreatment
Number of subjects: 1823
Study 15382303 — intervention group
Group type: EXPERIMENTAL
Intervention: CMT with surgery and chemotherapy
Number of subjects: 0
Study 15382303 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 0
Study 15382303 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0
Study 15382303 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery after chemotherapy
Number of subjects: 0
Study 15382303 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for mixed-histology cancer
Number of subjects: 0
Study 15382303 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat biopsy
Number of subjects: 0
Study 11500255 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 50
Study 11500255 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 9058513 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic regimen of interferon alpha‐2b (IFN‐alpha) at a dose of 10 MU/m2 body surface subcutaneously on 5 consecutive days every 4 weeks
Number of subjects: 23
Study 7937245 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 0
Study 7937245 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2851388 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 40
Study 2851388 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 40
Study 31198105 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifting straps (WS)
Number of subjects: 12
Study 31198105 — intervention group
Group type: COMPARATOR
Intervention: Without lifting straps (WOS)
Number of subjects: 12
Study 30196869 — intervention group
Group type: EXPERIMENTAL
Intervention: Strongest Families Smart Website (SFSW) intervention
Number of subjects: 464
Study 30196869 — intervention group
Group type: COMPARATOR
Intervention: Educational Control (EC)
Number of subjects: 464
Study 27616628 — intervention group
Group type: COMPARATOR
Intervention: BT (36-session group Internet behavioral weight control treatment)
Number of subjects: 398
Study 27616628 — intervention group
Group type: EXPERIMENTAL
Intervention: BT + MI (36-session group Internet behavioral weight control treatment + 6 individual MI chat sessions)
Number of subjects: 398
Study 24443783 — intervention group
Group type: EXPERIMENTAL
Intervention: CHANGE intervention schools
Number of subjects: 8
Study 24443783 — intervention group
Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 8
Study 21334858 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifamily Group Psychoeducation
Number of subjects: 47
Study 21334858 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution Focussed Group Therapy
Number of subjects: 47
Study 21334858 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual
Number of subjects: 47
Study 20482930 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat intake (LOFAT)
Number of subjects: 68
Study 20482930 — intervention group
Group type: EXPERIMENTAL
Intervention: High intake of fruits and vegetables (HIFV)
Number of subjects: 68
Study 20482930 — intervention group
Group type: COMPARATOR
Intervention: Comparison between LOFAT and HIFV
Number of subjects: 68
Study 18777606 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of static and dynamic magnetic fields (PEMF) applied 4 hours/day for 2 months
Number of subjects: 36
Study 18777606 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (placebo)
Number of subjects: 36
Study 18777606 — intervention group
Group type: EXPERIMENTAL
Intervention: Active PEMF exposure (after 2 months)
Number of subjects: 36
Study 18777606 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 36
Study 16108731 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-beta1a
Number of subjects: 0
Study 16108731 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-beta1a + pentoxifylline (PTX)
Number of subjects: 0
Study 15636358 — intervention group
Group type: EXPERIMENTAL
Intervention: External Qi-therapy (EQT)
Number of subjects: 10
Study 15636358 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 10
Study 10763797 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic exercise in the gym
Number of subjects: 90
Study 10763797 — intervention group
Group type: EXPERIMENTAL
Intervention: Home exercise
Number of subjects: 90
Study 10763797 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 8769692 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha)
Number of subjects: 600
Study 8769692 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy
Number of subjects: 600
Study 1564153 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin or erythromycin for 14 days with placebo added during the last 5 days
Number of subjects: 20
Study 1564153 — intervention group
Group type: COMPARATOR
Intervention: Penicillin or erythromycin for 14 days with rifampin added during the last 5 days
Number of subjects: 20
Study 4074614 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 60 mg
Number of subjects: 6
Study 4074614 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 120 mg
Number of subjects: 6
Study 4074614 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem 180 mg
Number of subjects: 6
Study 4074614 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 3481635 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg) during sodium repletion (100 mmol/day)
Number of subjects: 11
Study 3481635 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg) during sodium depletion (20 mmol/day)
Number of subjects: 11
Study 30514657 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious game 'Stop bullying now!', played for 20 minutes
Number of subjects: 150
Study 30514657 — intervention group
Group type: COMPARATOR
Intervention: Active control group, digital information package about bullying
Number of subjects: 150
Study 30514657 — intervention group
Group type: COMPARATOR
Intervention: Passive control group, digital information package not related to bullying
Number of subjects: 150
Study 28492198 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish (Fluor Protector)
Number of subjects: 60
Study 28492198 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine varnish (Cervitec Plus)
Number of subjects: 60
Study 28492198 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% Povidone-iodine (PI)
Number of subjects: 60
Study 28492198 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 25540221 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 18
Study 25540221 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 23296954 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium acetate (NaAc) ingestion
Number of subjects: 6
Study 23296954 — intervention group
Group type: COMPARATOR
Intervention: Sodium bicarbonate (NaHCO3) ingestion
Number of subjects: 6
Study 23296954 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium acetate (NaAc) ingestion during exercise
Number of subjects: 6
Study 23296954 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium acetate (NaAc) ingestion during final 75 min of exercise
Number of subjects: 6
Study 22332570 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck dissection (group ND)
Number of subjects: 132
Study 22332570 — intervention group
Group type: COMPARATOR
Intervention: Wait-and-see (group WS)
Number of subjects: 132
Study 22332570 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck dissection (group ND) for T1 cases
Number of subjects: 132
Study 22332570 — intervention group
Group type: COMPARATOR
Intervention: Wait-and-see (group WS) for T1 cases
Number of subjects: 132